Idebenone Decreases Aβ Pathology by Modulating RAGE/Caspase-3 Signaling and the Aβ Degradation Enzyme NEP in a Mouse Model of AD
Sign Up to like & getrecommendations! Published in 2021 at "Biology"
DOI: 10.3390/biology10090938
Abstract: Simple Summary The present study reveals that the FDA-approved drug idebenone has therapeutic effects on the pathology of Alzheimer’s disease (AD) in a mouse model. In particular, idebenone regulates pathological progression associated with Aβ by… read more here.
Keywords: rage caspase; pathology; idebenone; caspase signaling ... See more keywords